TargetMol

Bufetolol

Product Code:
 
TAR-T23836
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T23836-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23836-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T23836-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Bufetolol is an antagonist of beta-adrenoceptor.
CAS:
53684-49-4
Formula:
C18H29NO4
Molecular Weight:
323.433
Purity:
0.98
SMILES:
CC(C)(C)NC[C@@H](O)COc1ccccc1OC[C@@H]1CCCO1

References

1. Kudo S, Nozawa Y. Different effects of various beta-adrenoceptor antagonists on adenylate cyclase, guanylate cyclase and calmodulin-dependent phosphodiesterase in heart. Biochem Pharmacol. 1985 May 15;34(10):1659-64. PubMed PMID: 2860906. 2. Kimura T, Satoh S. Presynaptic inhibition by serotonin of cardiac sympathetic transmission in dogs. Clin Exp Pharmacol Physiol. 1983 Sep-Oct;10(5):535-42. PubMed PMID: 6315283. 3. Sada H, Harada S, Ban T. Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1983 Sep;324(1):50-7. PubMed PMID: 6138715. 4. Tsukiyama H, Otsuka K, Horii M, Yoshii Y, Hatori Y, Nakamura Y, Nemoto E, Yamato T, Sakai T, Yamamoto Y. Possible significance of the pharmacological differentiation of beta-blocking agents in hemodynamic effects in essential hypertension. Jpn Circ J. 1983 Mar;47(3):313-22. PubMed PMID: 6132016.